
Reset all filters
01 1ROVI ESCÚZAR, SL
Reset all filters
01 1Ilsung IS Co., Ltd.
Reset all filters
01 1Bemiparin sodium
Reset all filters
01 1Blank
Registrant Name : Ilsung IS Co., Ltd.
Registration Date : 2025-02-21
Registration Number : 20250221-211-J-1761
Manufacturer Name : ROVI ESCÚZAR, SL
Manufacturer Address : Avenida de la Serrezuela, 5518130 ESCÚZAR (GRANADA), SPAIN
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
38
PharmaCompass offers a list of Dalteparin sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dalteparin sodium manufacturer or Dalteparin sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dalteparin sodium manufacturer or Dalteparin sodium supplier.
PharmaCompass also assists you with knowing the Dalteparin sodium API Price utilized in the formulation of products. Dalteparin sodium API Price is not always fixed or binding as the Dalteparin sodium Price is obtained through a variety of data sources. The Dalteparin sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Heparin sodium 5,000 units in sodium chloride 0.45% manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Heparin sodium 5,000 units in sodium chloride 0.45%, including repackagers and relabelers. The FDA regulates Heparin sodium 5,000 units in sodium chloride 0.45% manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Heparin sodium 5,000 units in sodium chloride 0.45% API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Heparin sodium 5,000 units in sodium chloride 0.45% manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Heparin sodium 5,000 units in sodium chloride 0.45% supplier is an individual or a company that provides Heparin sodium 5,000 units in sodium chloride 0.45% active pharmaceutical ingredient (API) or Heparin sodium 5,000 units in sodium chloride 0.45% finished formulations upon request. The Heparin sodium 5,000 units in sodium chloride 0.45% suppliers may include Heparin sodium 5,000 units in sodium chloride 0.45% API manufacturers, exporters, distributors and traders.
click here to find a list of Heparin sodium 5,000 units in sodium chloride 0.45% suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Heparin sodium 5,000 units in sodium chloride 0.45% Drug Master File in Korea (Heparin sodium 5,000 units in sodium chloride 0.45% KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Heparin sodium 5,000 units in sodium chloride 0.45%. The MFDS reviews the Heparin sodium 5,000 units in sodium chloride 0.45% KDMF as part of the drug registration process and uses the information provided in the Heparin sodium 5,000 units in sodium chloride 0.45% KDMF to evaluate the safety and efficacy of the drug.
After submitting a Heparin sodium 5,000 units in sodium chloride 0.45% KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Heparin sodium 5,000 units in sodium chloride 0.45% API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Heparin sodium 5,000 units in sodium chloride 0.45% suppliers with KDMF on PharmaCompass.